Article Text

Companion Animal Practice
Options for the use of chemotherapy in small animals Part 1. Anticancer drugs
  1. Jane Dobson

    Jane Dobson graduated from the Royal Veterinary College, London, in 1982. In 1984, she moved to the department of clinical oncology and radiotherapeutics, Cambridge, and in 1989 gained a DVetMed for studies on the use of hyperthermia in the treatment of cancer. She is currently lecturer in veterinary clinical oncology in the department of clinical veterinary medicine, Cambridge, where her main interests are anticancer chemotherapy, radiation therapy and breed-associated cancers in dogs. She is a diplomate of the European College of Veterinary Internal Medicine (Companion Animals).


CHEMOTHERAPY has become an accepted method of cancer treatment in small animal practice and the indications for cytotoxic drugs are ever increasing. Yet, none of the products available are licensed for veterinary application and, to many veterinary surgeons, the use of cytotoxic drugs remains an unfamiliar and complex subject. In this, the first of two articles addressing options for the use of chemotherapy in small animal practice, the basic principles of anticancer treatment are discussed, with consideration of toxicity and safety issues. Specific indications for cytotoxic drugs, treatment protocols and the results that can be achieved with the use of such agents in small animal patients will be discussed in the next issue.

Statistics from

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.